£515.00

The 2023-2028 Outlook for Allergic Rhinitis Treatments in India

Subjects

Price data last checked 15 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 76 days · 76 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 76 days • 1 price levels

Days at Price

Price Analysis

Most common price: £515 (76 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 76 days

Description

This study covers the latent demand outlook for allergic rhinitis treatments across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of its state or union territory and of India as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state, union territory, and city, latent demand estimates are created for allergic rhinitis treatments. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of allergic rhinitis treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Alcon (Novartis AG), AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Merck, Sanofi, and Teva Pharmaceutical Industries. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format: paperback
ASIN: B0BGKZBM2T
Category: Books > Subjects
Domain: Amazon UK
Release Date: 14 September 2022
Listed Since: 29 September 2022

The 2023-2028 Outlook for Allergic Rhinitis Treatments in India

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2023-2028 Outlook for Allergic Rhinitis Treatments in the United States

The 2026-2031 World Outlook for Allergic Rhinitis Treatments

The 2025-2030 World Outlook for Allergic Rhinitis

The 2023 Report on Allergic Rhinitis Treatments: World Market Segmentation by City

The 2023-2028 Outlook for Allergy Treatments in India

The 2023-2028 Outlook for Allergy Treatments in the United States

The 2023-2028 Outlook for Allergy Care in India

The 2023-2028 Outlook for Systemic Antihistamines and Allergy Medications in India

The 2023-2028 Outlook for Systemic Antihistamines and Allergy Medications in the United States

Allergic Rhinitis

The 2023-2028 Outlook for Allergy Drugs in the United States

The 2023-2028 Outlook for Allergy Treatments in China

The 2016-2021 Outlook for Allergy Drugs in the United States

The 2023-2028 Outlook for Children's Allergy Medications in the United States

Rhinitis and Sinusitis, An Issue of Immunology and Allergy Clinics of North America (Volume 46-1) (The Clinics: Internal Medicine, Volume 46-1)

The 2016-2021 Outlook for Systemic Antihistamines and Allergy Medication in Greater China

The 2016-2021 Outlook for Allergy Drugs in Japan

The 2016-2021 Outlook for Allergy Drugs in Greater China

The 2023-2028 Outlook for Children's Allergy Medications in India

The 2023-2028 World Outlook for Children's Allergy Medications

The 2025-2030 World Outlook for Allergy Care

The 2016-2021 Outlook for Children's Allergy Medication in Japan

The 2023 Report on Children's Allergy Medications: World Market Segmentation by City

The 2023-2028 Outlook for Allergy Care in China